PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 10, 2026Egyptian Pediatric Association Gazette0 citationsOpen Access

The current landscape of pediatric oncology in Nigeria: a scoping review of diagnostic delays, treatment access, and outcomes

View Full Paper
NBNwamaka Chidera Bob-UmeEOEsther Oluwafunmilayo OmotosoJAJohnPaul Steve Akpabio

Key Points

  • The aim is to examine the factors affecting pediatric cancer care in Nigeria, focusing on diagnostic delays, treatment access, and outcomes.
  • Conducted a scoping review of literature published from 2005-2025 regarding pediatric oncology in Nigeria.
  • Searched multiple databases including PubMed and Scopus for eligible English-language studies.
  • Synthesized findings thematically and narratively from 27 studies involving 2,920 patients.
  • Symptom-to-presentation intervals ranged from 2 to 157 weeks, with a median of 79.5 weeks.
  • Treatment completion rates varied significantly between studies, ranging from 3.3% to 62.8%.
  • Mortality rates reported in studies varied widely, from 6.3% to 45.1%.

Abstract

Abstract Background Pediatric cancer care in Nigeria is constrained by several patient- and system-related factors. In line with the World Health Organization’s Global Initiative for Childhood Cancer, this scoping review mapped the Nigerian literature on diagnostic delays, treatment access, clinical outcomes, and related system gaps. Methods We searched PubMed, Cochrane Library, Scopus, African Journals Online (AJOL), Taylor treatment discontinuation was 6.3% in one study and 64.7% in another; mortality was 6.3% in one study and 45.1% in another; and cohort-level loss to follow-up was 6.6% in one study and 52.6% in another, reaching 81.8% among patients discharged on follow-up chemotherapy in one cohort. Conclusion Pediatric oncology care in Nigeria is marked by prolonged diagnostic pathways, interrupted treatment, and poor reported outcomes. Priorities include standardized referral pathways and integration of childhood cancer into national health insurance. Graphical abstract

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Bob-Ume et al. (2026) studied this question.

synapsesocial.com/papers/6a0021e6c8f74e3340f9cd55https://doi.org/10.1186/s43054-026-00551-2
Ask AI
Helpful
Bookmark
Share
View Full Paper